GGrantIndex
Sort

261,768 grants matching gene therapy

Gene Therapy for Metachromatic Leukodystrophy

$1,598,287
Ronald G Crystal · Weill Medical Coll Of Cornell Univ · U01 · FY2014 · NS

Migraine Pathophysiology and Treatment Mechanisms

$1,598,019
Massachusetts General Hospital · P01 · FY2005 · NS

Migraine Pathophysiology and Treatment Mechanisms

$1,598,019
Massachusetts General Hospital · P01 · FY2004 · NS

Migraine Pathophysiology and Treatment Mechanisms

$1,598,019
Massachusetts General Hospital · P01 · FY2003 · NS

Migraine Pathophysiology and Treatment Mechanisms

$1,598,019
Massachusetts General Hospital · P01 · FY2002 · NS

High-Resolution Native Capillary Zone Electrophoresis with Inline UV and Native Mass Spectrometry for Characterizing Charge Variants in Biologics

$1,597,901
Oluwatosin Dada · Gmj Technologies, Inc. · R44 · FY2025 · GM

Vanderbilt Proteome Characterization Center

$1,597,507
Bing Zhang · Vanderbilt University · U24 · FY2015 · CA

The role of Galpha13 signaling in suppression of lymphoma

$1,597,365
Jagan Muppidi · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

Interventional approaches for restoring vision

$1,597,340
Anand Swaroop · National Eye Institute · ZIA · FY2019 · EY

BASIC AND CLINICAL STUDIES OF COAGULATION PROTEINS

$1,597,265
University Of Rochester · P01 · FY2001 · HL

A system approach to targeting innate immunity in AD

$1,597,190
Todd E. Golde · University Of Florida · U01 · FY2015 · AG

Comprehensive dissection of the CLL genome & phenome to improve patient outcomes

$1,596,896
Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · P01 · FY2023 · CA

Immunologic control of HIV-1 through combination bNAbs and biologics.

$1,596,752
Marina Caskey · Rockefeller University · U01 · FY2023 · AI

CHILDHOOD SOLID TUMORS

$1,596,749
St. Jude Children'S Research Hospital · P01 · FY2001 · CA

Role of microbiome in cancer and inflammation

$1,596,434
Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

Comprehensive dissection of the CLL genome & phenome to improve patient outcomes

$1,596,329
Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · P01 · FY2022 · CA

Washington University Molecular Imaging Center

$1,596,254
David R Piwnica-Worms · Washington University · P50 · FY2008 · CA

Alcohol Pharmacokinetics and Pharmacodynamics in Humans

$1,596,171
Vijay Arjun Ramchandani · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2021 · AA

A Phase I Clinical Trial Testing Feasibility of Hematopoietic Stem Cell Gene Therapy Using Platelet Factor VIII to Safely Improve Hemostasis for Severe Hemophilia A with Inhibitory Antibodies

$1,596,167
David Allen Wilcox · Medical College Of Wisconsin · R01 · FY2020 · HL

Genetic predictors of response to anti-TNF therapy in rheumatoid arthritis

$1,596,048
Robert M Plenge · Brigham And Women'S Hospital · U01 · FY2012 · GM

EFFICACY AND SAFETY EVALUATION OF LEAD GENE THERAPY CANDIDATE IN NEUROMUSCULAR JUNCTION (NMJ) DISEASE MOUSE MODELS AND BIOANALYTICAL ASSAY METHODS DEVELOPMENT

$1,595,870
Mike Robertson · Lovelace Biomedical Research Institute · N01 · FY2023 · DA

The Impact of Maternal Health and Diet on Development of Fetal Metabolic Systems

$1,595,849
Kevin L Grove · Oregon Health & Science University · R24 · FY2012 · DK

PPG: SARS-CoV-host cell interactions and vaccine development

$1,595,796
Stanley Perlman · University Of Iowa · P01 · FY2014 · AI

PPG: SARS-CoV-host cell interactions and vaccine development

$1,595,795
Stanley Perlman · University Of Iowa · P01 · FY2012 · AI

PPG: SARS-CoV-host cell interactions and vaccine development

$1,595,795
Stanley Perlman · University Of Iowa · P01 · FY2015 · AI